In patients with obesity and type 2 diabetes, adipose tissue is infiltrated by macrophages known to alter adipogenesis of mesenchymal precursor cells via secretion of proinflammatory cytokines. Recently, it has been shown that under certain conditions, immune cells can also express wnt-5a, a factor known to inhibit adipogenesis in humans. Therefore, in this study we aimed to investigate whether macrophages affect adipogenesis of mesenchymal precursor cells via wnt-5a. Wnt-5a was found to be expressed in adipose tissue macrophages in obese and type 2 diabetic human subjects in vivo by immunohistochemistry of adipose tissue biopsies. Furthermore, wnt-5a was detectable in circulating CD14 þ blood monocytes of human subjects with obesity and type 2 diabetes on RNA level by real-time PCR. Besides expression analysis in vivo, we also performed functional studies to explore the role of wnt-5a in low-grade inflammation of adipose tissue. In a cell culture experiment, macrophageconditioned differentiation medium inhibited adipogenesis of 3T3-L1 cells. This inhibitory effect was restored by adding neutralising anti-wnt-5a antibodies. In conclusion, our data indicate that macrophages alter adipogenesis of 3T3-L1 cells not only via classical proinflammatory cytokines, but also via wnt signalling molecules.
Within the past several years, low-grade inflammation has been shown to be important in the pathogenesis of metabolic disorders like insulin resistance and type 2 diabetes in obese human subjects. 1 For example, the stromavascular fraction of human adipose tissue contains up to 10% resident macrophages. 2 It should be pointed out that fat biopsies from obese human subjects were found to be infiltrated by an increased number of macrophages compared with lean controls, 3 suggesting that the number of macrophages is crucial in the concept of low-grade inflammation of adipose tissue. Furthermore, substantial weight losses significantly lowered the number of macrophages in adipose tissue in humans. 4 Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells, thereby limiting the expansion of human adipose tissue. This finding is thought to result in two abnormalities: (1) excessive energy has to be stored in the existing adipocytes that thereby exhibit a marked enlargement known to be associated with insulin resistance; 5 (2) furthermore, the reduced capacity of adipose tissue might lead to ectopic lipid accumulation in liver and skeletal muscle, resulting in insulin resistance of these metabolically important tissues. 6 On a molecular level, in murine cell culture models and mice, adipose tissue development and function has been shown to be altered by the proinflammatory cytokine tumour necrosis factor-a. 7 However, in human subjects treated with the anti-tumour necrosis factor-a antibody adalimumab 8 or the soluble tumour necrosis factor-a receptor etanercept, 9 insulin sensitivity was not significantly improved. These findings might suggest that in the human organism, macrophages affect adipose tissue biology via different bioactive molecules. Wnt signalling molecules have first been described to inhibit adipogenesis in murine cells in the year 2000. 10 Whereas in mice canonical wnt-10b seems to be crucial, in a recent report from our group in human adipogenesis, non-canonical wnt-5a was found to be an important antiadipogenic molecular regulator. 11 Wnt-5a has also been found to be expressed in macrophages in solid tumours. 12 Moreover, wnt-5a levels in macrophages in humans have been shown to be upregulated in sepsis, a pathophysiological condition with high inflammatory activity. 13 In this study we aimed to investigate if adipose tissue macrophages in obese and type 2 diabetic human individuals express wnt-5a in vivo. Therefore, we performed immunohistochemistry for wnt-5a of adipose tissue biopsies. In this analysis, adipose tissue macrophages were positive for wnt-5a in obese and type 2 diabetic human subjects (Figure 1a ). Several macrophages in adipose tissue of obese and type 2 diabetic human subjects were found to be localised in the so-called crown-like structures, surrounding individual adipocytes (Figure 1a) . However, wnt-5a expression of adipose tissue macrophages was not restricted to individuals with obesity and type 2 diabetes, as the few macrophages found in fat biopsies from lean control subjects were also detected positive for wnt-5a (Figure 1b) .
Expression of wnt-5a was also examined in circulating blood monocytes, the cell population from which tissue macrophages generate. As shown in Figure 1c , wnt-5a was detectable in these cells on RNA and also on protein level in human subjects. We next aimed to investigate if wnt-5a expression levels in blood monocytes differ between lean control subjects, subjects with obesity and patients with obesity and type 2 diabetes. Therefore, we isolated monocytes from blood samples of human subjects by CD14 MACS (magnetic cell sorting) and performed real-time reverse transcriptase-PCR for wnt-5a. In this analysis, wnt-5a was detectable in all human subjects examined. No significant difference in relative expression levels was observed between the groups (Figure 1d ). Finally, to ensure that wnt-5a is not only expressed in mononuclear cells but also secreted, we performed western blot analysis for wnt-5a of serum-free medium supernatants of a macrophage cell culture, clearly demonstrating that wnt-5a is secreted by these inflammatory cells ( Figure 1e ).
Having shown that wnt-5a is expressed in adipose tissue macrophages in humans in vivo, we next aimed to investigate if wnt-5a secreted from macrophages inhibits adipogenesis of mesenchymal precursor cells in a cell culture experiment. Therefore, we generated the so-called macrophage-conditioned medium by incubating Dulbecco's modied Eagle's medium culture for 2 h on a J774 macrophage culture. Afterwards, the medium was removed and centrifuged to separate floating cells. This medium containing all secretion products from macrophages was then used to generate preadipocyte differentiation medium. As shown in Figure 2 , incubation in macrophage-conditioned medium resulted in a significant impairment of preadipocyte differentiation compared with fresh differentiation medium. When neutralising anti-wnt-5a antibodies were added to the macrophage-conditioned medium, adipogenic potential was significantly restored.
Taken together, in this study we aimed to explore the potential role of wnt-5a in low-grade inflammation of adipose tissue of obese human subjects with type 2 diabetes. Our data demonstrate that wnt-5a is expressed in adipose tissue macrophages in obese and type 2 diabetic human subjects in vivo. However, the few macrophages found in adipose tissues of lean control subjects were also positive for wnt-5a. As in immunohistochemistry expression levels are difficult to quantify and to compare between groups, we also prepared circulating blood monocytes from blood samples of lean controls, obese non-diabetic individuals and obese patients with type 2 diabetes, as tissue macrophages are known to generate from these cells. When wnt-5a expression levels in these inflammatory precursor cells were quantified by real-time PCR on RNA level, we did not observe a difference between the groups. This might suggest that the pronounced inhibitory effects of wnt-5a on adipose tissue biology in obese and type 2 diabetic subjects are predominantly because of the increased number of macrophages found in these subjects 3 rather than an increased activation of the individual mononuclear cell. Alternatively, wnt-5a expression might be increased when monocytes transform into macrophages after invasion into adipose tissue, and that will be an interesting topic for future studies. Besides investigation of wnt-5a expression in monocytes and macrophages in humans in vivo in this study, we also performed functional studies in vitro showing that wnt-5a secreted by macrophages indeed inhibits adipogenesis.
In conclusion, our data suggest that adipose tissue macrophages affect not only preadipocyte differentiation via classical proinflammatory cytokines, but also via wnt signalling molecules.
Patients and methods

Study population
The study was approved by the local ethics committee and written informed consent was obtained from all participants. Subcutaneous adipose tissue biopsies were taken during elective surgical procedures from lean controls (n ¼ 11, mean age 53 years, 72% males), obese subjects (n ¼ 12, mean age 48 years, 42% males) and obese human individuals with type 2 diabetes (n ¼ 5, mean age 58 years, 60% males). Exclusion criteria were: acute or chronic infectious or immunological disease, cancer, elevation of liver function tests 43-fold of normal range, serum-creatinin levels 41.5 mg dl -1 , hyper-and hypo-cortisolism, hyper-or hypothyroidism and lipodystrophy. In the lean control group, five patients were on antihypertensive drugs, four patients on antacids, one patient took iron substitution and one patient took thyroid hormones. In the obese group, six patients were on antihypertensive drugs, three patients were on thyroid replacement therapy, two patients took antacids, one patient took allopurinol and one patient digitoxin. In the obese and diabetic group, one patient was on insulin and three on metfromin therapy whereas one patient was on dietary intervention only. All patients took antihypertensive drugs, Adipose tissue macrophages and wnt signalling R Bilkovski et al two patients took antacids, two patients took lipid-lowering drugs, one patient was on carbamazepine therapy, one patient took acetylsalicylic acid and one patient took thyroid hormones. In order to compare levels of wnt-5a expression in circulating blood monocytes, blood samples were taken from lean controls (n ¼ 17), obese human individuals (n ¼ 20) and patients with obesity and type 2 diabetes (n ¼ 19).
Inclusion and exclusion criteria for this study population and patients characteristics have been described earlier. 14 
Immunohistochemistry and western blotting
Human adipose tissue biopsies were fixed in 4% paraformaldehyde/phosphate-buffered saline solution for 24 h at 4 1C. ¼ 19) . Taqman real-time PCR (Applied Biosystems, Carlsbad, CA, USA). Mean±s.e.m., NS, nonsignificant, Student's t-test. (e) wnt-5a is secreted by mononuclear cells. J744 macrophages were cultured to 70% confluence under standard conditions. Afterwards, medium was removed and cells were incubated for 2 h in serum-free Dulbecco's modied Eagle's medium (DMEM). Subsequently, supernatants were concentrated using Amicon (Millipore Amicon, Billerica, MA, USA) Centricon Centrifugal Filter Devices (MW 30.000) and applied to a western blot (macrophage-conditioned medium). As a control, fresh serum-free medium was used in the western blotting experiment.
Adipose tissue macrophages and wnt signalling R Bilkovski et al Samples were dehydrated by ascending ethanol series and embedded in paraffin. Sections of this embedded sample (4 mm) were assembled and dried on tissue slides. Dewaxing was achieved by xylol and 100% ethanol following rehydration by descending ethanol series. Rehydrated samples were washed with phosphate-buffered saline and blocked for 1 h with Rotiblock (Carl Roth, Karlsruhe, Germany). Overnight incubation with galectin-3 (sc-56108; Santa Cruz Biotech Company, Santa cruz, CA, USA) or wnt-5a antibodies (sc-30224; Santa Cruz) was performed at 4 1C. Subsequently, samples were washed 3 Â 5 min in phosphate-buffered saline and incubated for 1 h with a second horseradish peroxidaseconjugated antibody (A4416; Sigma Aldrich (St Louis, MO, USA), Vector (Burlingame, CA, USA) PI 1000). This was followed by an incubation with 3,3 0 -diaminobenzidin as well as haematoxylin for counterstaining. Subsequently, samples The CaMKII-TAK1-TAB2-NLK pathway is known to be activated by wnt-5a in preadipocytes. 16 Therefore, we examined phospho-TAK levels as a marker of wnt-5a activity in the different groups. Shown is one representative example and a densitometry of n ¼ 5 independent experiments of a western blot for phospho-TAK. (c) Expression of the molecular marker peroxisome proliferator-activated receptor (PPAR-g). PPAR-g is a proadipogenic transcription factor known to be inhibited by wnt-5a via the CaMKII-TAK1-TAB2-NLK pathway in preadipocytes. 16 Therefore, PPAR-g expression was examined in the different groups by western blot. Shown is one representative sample and a densitometry of n ¼ 5 independent experiments. (b and c) Mean±s.e.m., Student's t-test, *Po0.05. In these experiments, b-actin expression was used as a loading control for normalisation.
Adipose tissue macrophages and wnt signalling R Bilkovski et al were dehydrated and analysed by immunofluorescence microscopy. Western blotting was performed as described earlier 15 using the following primary antibodies: wnt-5a
(sc-23698; Santa Cruz), peroxisome proliferator-activated receptor-g (2430; Cell Signalling, Danvers, MA, USA) and b-actin (69100; MP Biomedicals, Solon, OH, USA). Corresponding secondary antibodies were obtained from Sigma.
Isolation of CD14-positive circulating blood monocytes and reverse transcriptase-PCR CD14-positive circulating blood monocytes were isolated by magnetic cell sorting as described earlier. 14 
